Back to results
US 7,741,287 B2Granted
Peptides for the treatment of herpes virus infections
AssigneeIPF PharmaCeuticals GmbH
InventorsWolf-Georg Forssmann, Frank Kirchhoff, Jan Münch, Ludger Ständker
Life of this patent
Estimating the term…
Abstract
The present invention relates to the use of a peptide having the amino acid sequence NH2-VCVLAHHFGKEFTPPVQAAYQKVVAGVANALAHKYH-COOH (SEQ ID NO:1) as well as variants, derivatives and fragments of the peptide for the treatment of viral diseases.
Claims6
A method for treating viral disease comprising:
- administering to a subject in need thereof an effective amount of a peptide consisting of the amino acid sequence SEQ ID NO:1, or an amidated, acetylated, sulfated, phosphorylated, glycosylated, oxidized or polyethylene glycol-modified derivative thereof, wherein said derivative has inhibitory activity against HSV-2 in a cellular infection assay.
Dependencies are inferred from the claim text.